Otonomy Reports Third Quarter 2015 Financial Results and Provides Corporate Update

Back to Jobs

SAN DIEGO , Nov. 10, 2015 (GLOBE NEWSWIRE) — Otonomy, Inc. (NASDAQ:OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, today reported financial results for the quarter ended September

Apply Now